May 28, 2021
455th Edition, May 11, 2021
BioHealth Innovation If you are having trouble viewing this email, please click here May 11,…
May 26, 2021
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® (ustekinumab) Biosimilar | Business Wire
FREDERICK, Md.--(BUSINESS WIRE)--BioFactura, a leading developer of high-value biosimilar and biodefense drugs using its patented…
May 26, 2021
NIH spinout raises millions to attack drug-resistant cancers with RNA. It has big plans. · BioBuzz
A local biotech has secured millions of dollars in new investments to take its RNA therapies for…
May 25, 2021
miRecule Inc. closes $5.7 M to Create Breakthrough RNA Therapies for Cancer and Muscular Dystrophy
Gaithersburg, MD. (May ____ 2021) miRecule, Inc. (“miRecule”), an emerging biotech company focused on the…
May 24, 2021
NIH spinout fighting cancer with RNA therapeutics raises millions – Washington Business Journal
The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other…
